The Injection (Subcutaneous) - Dosing: Once weekly - Bioavailability: ~100% (bypasses GI tract) - Weight loss in trials: Up to 22% at 36 weeks - Best for: Patients seeking maximum efficacy, comfortable with self-injection The Pill (Oral) - Dosing: Once daily (taken on an empty stomach, similar to Rybelsus) - Bioavailability: Lower than SC (relies on SNAC absorption technology) - Weight loss in trials: Up to 13.1% at 12 weeks (Phase 1 short duration) - Best for: Injection-averse patients, early treatment, maintenance, broader access The oral formulation will almost certainly deliver less weight loss than the subcutaneous version at equivalent treatment durations
The solution should look clear with a faint blue tint from the copper complex
However, remember that research is inadequate regarding the efficacy and potential side effects of glutathione
doi: 10.1007/s00134-023-07263-w [PubMed] 38170117 Gidal BE, Resnick T, Smith MC, Wheless JW
Embracing this form of TB-500 allows for a smoother research experience, potentially advancing our understanding of its therapeutic properties